Register to attend live via webinar HERE!

This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.

KEYNOTE SPEAKERS
James P. Allison, PhD, MD Anderson Cancer Center;
Jeffrey Bluestone, PhD, University of California, San Francisco;
Philip D. Greenberg, MD, Fred Hutchinson Cancer Research Center;
Jedd Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center